Protagenic Therapeutics executive chair Garo H. Armen buys 2,220 shares for $710.4
PTIX•Insider share purchase
- Protagenic Therapeutics Executive Chair and Principal Officer Garo H. Armen bought 2,220 common shares at USD 0.32 each.
- Directly held common stock position rose to 34,199 shares.
